{
 "PrintNo":"A5354","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-02-13T15:33:46.025233Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2026-01-07","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2025-02-13","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2026-01-07","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":675,"Name":"Phil Steck","Short":"STECK"}],
 "Title":"Requires health insurers to provide coverage without cost-sharing for opioid antagonists and devices",
 "Summary":"Requires health insurers to provide coverage without cost-sharing for opioid antagonists and devices; provides that no prior authorization of premedical review for coverage of such opioid antagonist is required.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to requiring health insurers to provide coverage without cost-sharing for opioid antagonists and devices"
}